Arecibo

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Retinitis pigmentosa2 trials

Phase

• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Nanoscope Therapeutics Inc.2 trials

Running trials

• Active, not recruiting

  Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study

  NCT06162585· Nanoscope Therapeutics Inc.· Source

Closed trials

• Completed

  Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]

  NCT04945772· Phase 2· Nanoscope Therapeutics Inc.· Source